Advertisement
Advertisement
LFCR
Lifecore Biomedical, Inc. Common Stock
5.01
USDSponsored
+0.17
+3.51%
Aug 07, 15:58 UTC -4
Closed
After-Market
5.00
-0.01
-0.20%
LFCR Earnings Reports
Positive Surprise Ratio
LFCR beat 20 of 36 last estimates.
56%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Lifecore Biomedical, Inc. Common Stock earnings per share and revenue
On May 06, 2026, LFCR reported earnings of -0.43 USD per share (EPS) for Q1 26, missing the estimate of -0.24 USD, resulting in a -75.65% surprise. Revenue reached 23.19 million, compared to an expected 27.03 million, with a -14.20% difference. The market reacted with a -3.88% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$2.09
Actual
$2.21
Surprise
+5.69%
REGENXBIO Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.05
Actual
$0.43
Surprise
+626.35%
X4 Pharmaceuticals, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
SAB Biotherapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+5.15%
Cellectis S.A. - ADR
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.22
Surprise
+20.89%
Entera Bio Ltd. Ordinary Shares
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.14
Surprise
-71.57%
Genmab A/S ADS
Report Date
Aug 06, 2026 For Q2 26
Estimate
$3.59
Actual
$0.54
Surprise
-84.98%
Praxis Precision Medicines, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$3.73
Actual
-$2.87
Surprise
+23.14%
Halozyme Therapeutics, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.87
Actual
$2.27
Surprise
+21.75%
Cytokinetics Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$1.67
Actual
-$1.50
Surprise
+10.35%
FAQ
What were Lifecore Biomedical, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Lifecore Biomedical, Inc. Common Stock reported EPS of -$0.43, missing estimates by -75.65%, and revenue of $23.19M, -14.2% below expectations.
How did the market react to Lifecore Biomedical, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -3.88%, changed from $5.16 before the earnings release to $4.96 the day after.
When is Lifecore Biomedical, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Lifecore Biomedical, Inc. Common Stock's next earnings report?
Based on --
analysts, Lifecore Biomedical, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement